Abiomed celebrates $40 million expansion to Massachusetts headquarters
During a ceremony on March 30, Massachusetts Governor Charlie Baker and others celebrated the grand opening of Abiomed’s expanded headquarters in Danvers, Massachusetts.
Abiomed’s headquarters expanded from 60,000 square feet to 160,000 square feet. The company added new research and manufacturing capabilities and a new Heart Recovery Institute for clinical education, according to a company news release.
Since Abiomed broke ground on the project in June 2015, the company said it has added more than 150 engineering and manufacturing jobs at the site. The company also plans on expanding in Berlin and Aachen, Germany and Tokyo, Japan.
Abiomed manufactures the FDA-approved Impella 2.5, 5.0, CP and RP heart pumps. In February, the company announced that the 50,000th U.S. patients had been treated with an Impella heart pump.
Abiomed, which has been in Massachusetts since 1981, also honored two cardiac patients at the March 30 event who have benefited from the company’s technology. Abiomed named conference rooms after patients Rogelio Landin of Detroit and Howard Gaynor of Hartford, Connecticut.
Through the expansion, Abiomed has invested more than $40 million into Massachusetts for education, manufacturing and training, according to the company.
“With Massachusetts-based companies like Abiomed helping to lead the way, the Commonwealth continues to be a global leader in health care, innovation and technology,” Baker said in a news release. “I am pleased to continue to witness the growth of a company that has invested in Massachusetts for more than 35 years and we look forward to continuing to work together to create jobs and develop the state’s innovation economy.”